Differences

This shows you the differences between two versions of the page.

--- home:diseases:ms [01.18.2019] – [Notes and comments] sallieq
+++ home:diseases:ms [01.18.2019] – [Member experience] sallieq
@@ Line 106: / Line 106: @@
 (({{pubmed>long:15084504}}))
-===== Headline =====
+===== Of further interest =====
 By shedding light on the involvement of EBV in MS, these findings will pave the way to disease prevention and increase the therapeutic index of future treatments.
@@ Line 188: / Line 188: @@
-===== Recent research=====
+===== Recent Research=====
@@ Line 215: / Line 215: @@
 -Limburg
 </blockquote>
+<blockquote>On starting MP // Yomi posted// I was diagnosed with Sarcoidodis in 2001. I have had manifestaions obviously in the lungs but later in the eyes (uveitis) the skin (granluoma) and most recently in the nervous system (neuropathy).  I've got a decent case of lupus pernio pretty much all over my body. So these symptoms along with the neuropathy are taking its time as expected.
+(//questioned after 8 years how the lupus has responded//)
+It has some. The raised bumps on my face used to have a dark colored center. Now the bumps no longer have the dark colored center and aren't as swollen.</blockquote>
 These also present the treatment of Multiple Sclerosis with the Marshall Protocol.
@@ Line 226: / Line 233: @@
 Our simplified article in [[http://autoimmunityresearch.org/preprints/Proal_2013_CurrentOpinion-Preprint.pdf|Current Opinion in Rheumatology 2013]]
-{{tag>disease arrange}}
+{{tag>disease }}

home/diseases/ms.txt · Last modified: 09.14.2022 by 127.0.0.1